Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages 1678-1685

  Dueñas González, Alfonso ^{a,b,c,d,e,f,g,h,i,j}   Zarbá, Juan J ^{a,b,c,d,e,f,g,h,i,j}   Patel, Firuza ^{a,b,c,d,e,f,g,h,i,j}   Alcedo, Juan C ^{a,b,c,d,e,f,g,h,i,j}   Beslija, Semir ^{a,b,c,d,e,f,g,h,i,j}   Casanova, Luis ^{a,b,c,d,e,f,g,h,i,j}   Pattaranutaporn, Pittayapoom ^{a,b,c,d,e,f,g,h,i,j}   Hameed, Shahid ^{a,b,c,d,e,f,g,h,i,j}   Blair, Julie M ^{a,b,c,d,e,f,g,h,i,j}   Barraclough, Helen ^{a,b,c,d,e,f,g,h,i,j}   Orlando, Mauro ^{a,b,c,d,e,f,g,h,i,j}  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Medical Center   (Argentina)

^c Eli Lilly and Company   (Argentina)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e National Institute of Oncology   (Panama)

^f UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^g INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^j ELI LILLY AUSTRALIA PTY LTD   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADJUVANT THERAPY; ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTESTINE PERFORATION; KARNOFSKY PERFORMANCE STATUS; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; NEUTROPENIA; OPEN STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROGRESSION FREE SURVIVAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SIDE EFFECT; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; UTERINE CERVICAL NEOPLASMS;

EID: 79955582400     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.9663     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
2. Green JA, Kirwan JM, Tierney JF, et al: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 358:781-786, 2001 (Pubitemid 32868726)
3. Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161, 1999 (Pubitemid 29177874)
4. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143, 1999 (Pubitemid 29177872)
5. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153, 1999 (Pubitemid 29177873)
6. Whitney CW, Sause W, Bundy BN, et al: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339-1348, 1999 (Pubitemid 29220838)
7. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606-1613, 2000 (Pubitemid 30220538)
8. Rose PG: Chemoradiotherapy for cervical cancer. Eur J Cancer 38:270-278, 2002
9. Hernández P, Olivera P, Dueñas-Gonzalez A, et al: Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 48:488-492, 2001
10. Candelaria M, Garcia-Arias A, Cetina L, et al: Radiosensitizers in cervical cancer: Cisplatin and beyond. Radiat Oncol 1:15, 2006
11. Zarbá JJ, Jaremtchuk AV, Gonzalez Jazey P, et al: A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol 14:1285-1290, 2003 (Pubitemid 37039057)
12. Dueñas-González A, Cetina-Perez L, Lopez-Graniel C, et al: Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized phase II study. Int J Radiat Oncol Biol Phys 61:817-823, 2005
13. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and metaanalysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802-5812, 2008
14. American Joint Committee on Cancer: Cervix uteri, in: AJCC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, pp 190-191
15. Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
16. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343-346, 1996 (Pubitemid 26342716)
17. Eifel PJ, Winter K, Morris M, et al: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22:872-880, 2004 (Pubitemid 41103599)
18. Green J, Kirwan J, Tierney J, et al: Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3:CD002225, 2005
19. Umanzor J, Aguiluz M, Pineda C, et al: Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial. Gynecol Oncol 100:70-75, 2006 (Pubitemid 41815052)
20. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (CCCMAC): Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis. Cochrane Database Syst Rev 1:CD008285, 2010
21. Monk BJ, Tian C, Rose PG, et al: Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol 105:427-433, 2007 (Pubitemid 46613901)
22. Winter WE 3rd, Maxwell GL, Tian C, et al: Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: A Gynecologic Oncology Group study. Gynecol Oncol 94:495-501, 2004 (Pubitemid 39024559)
23. Puget Sound Oncology Consortium, Swisher EM, Swensen RE, et al: Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol 101:429-435, 2006 (Pubitemid 43729965)
24. Rose PG, Degeest K, McMeekin S, et al: A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol 107:274-279, 2007 (Pubitemid 47575725)
25. Perez CA, Grigsby PW, Castro-Vita H, et al: Carcinoma of the uterine cervix: I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 32:1275-1288, 1995
26. Chen SW, Liang JA, Yang SN, et al: The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 67:69-76, 2003